Cargando…
Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient
Little is known about the effect of oncolytic adenovirotherapy on pediatric tumors. Here we present the clinical case of a refractory neuroblastoma that responded positively to Celyvir (ICOVIR-5 oncolytic adenovirus delivered by autologous mesenchymal stem cells) for several months. We analyzed samp...
Autores principales: | Franco-Luzón, Lidia, García-Mulero, Sandra, Sanz-Pamplona, Rebeca, Melen, Gustavo, Ruano, David, Lassaletta, Álvaro, Madero, Luís, González-Murillo, África, Ramírez, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281487/ https://www.ncbi.nlm.nih.gov/pubmed/32354143 http://dx.doi.org/10.3390/cancers12051104 |
Ejemplares similares
-
Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology
por: Ramírez, Manuel, et al.
Publicado: (2015) -
Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
por: Franco-Luzón, Lidia, et al.
Publicado: (2020) -
Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022) -
Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression
por: García-Mulero, Sandra, et al.
Publicado: (2021) -
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
por: Castet, Florian, et al.
Publicado: (2019)